Publications

Review Article

Vaccination against the HER-2/neu oncogenic protein

Cancer Vaccines

2002

Authors:

Bernhard H, Salazar L, Schiffman K, Smorlesi A, Schmidt B, Knutson K, and Disis M

Journal:

Endocrine- related Cancer

Volume:

Page:

33-44

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/11914181/

Review Article

Adoptive T-cell therapy for the treatment of solid tumours

T Cell Function & Therapy

2002

Authors:

Knutson KL, Almand B, Mankoff DA, Schiffman K, and Disis ML

Journal:

Expert Opinion on Biological Therapy

Volume:

2(1)

Page:

55-66

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/11772340/

Original Article

Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer

T Cell Function & Therapy

2001

Authors:

McNeel DG, Nguyen LD, Ellis WJ, Higano CS, Lange PH, Disis ML

Journal:

Prostate

Volume:

47(3)

Page:

222-9

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/11351352/

Original Article

Issues on clinical applications of cancer vaccines

Cancer Vaccines

2001

Authors:

Disis ML and Schiffman K

Journal:

Journal of Immunotherapy

Volume:

24(2)

Page:

104-5

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/11265766/

Original Article

Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients

Cancer Vaccines

2001

Authors:

Knutson KL, Schiffman K, Disis ML

Journal:

The Journal of Clinical Investigation

Volume:

107(4)

Page:

477-84

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/11181647/

Original Article

Expansion of HER2/neu-specific T cells ex vivo following immunization with a HER2/neu peptide-based vaccine

Cancer Vaccines

2001

Authors:

Knutson KL, Disis ML

Journal:

Clinical Breast Cancer

Volume:

2(1)

Page:

73-79

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/11899386/

Original Article

Identification of T helper epitopes from prostatic acid phosphatase

Cancer Vaccines

2001

Authors:

McNeel DG, Nguyen LD, Disis ML

Journal:

Cancer Research

Volume:

61(13)

Page:

5161-7

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/11431355/

Review Article

Clinical translation of peptide-based vaccine trials: the HER-2/neu model

Cancer Vaccines

2001

Authors:

Disis ML, Knutson KL, McNeel DG, Davis D, and Schiffman K

Journal:

Critical Reviews in Immunology

Volume:

21(1-3)

Page:

263-73

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/11642608/

Original Article

HER2/neu peptide-based vaccines, with GM-CSF as an adjuvant, in patients with advanced-stage HER2/neu-expressing cancers

Cancer Vaccines

2000

Authors:

Schffman K and Disis ML

Journal:

Clinical Lung Cancer

Volume:

2(1)

Page:

74-7

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/14731345/

Original Article

Antibody immunity to prostate cancer associated antigens can be detected in the serum of patients with prostate cancer

Cancer Vaccines

2000

Authors:

McNeel DG, Nguyen LD, Storer BE, Vessella R, Lange PH, and Disis ML

Journal:

Journal of Urology

Volume:

164(5)

Page:

1825-9

Pubmed:

https://pubmed.ncbi.nlm.nih.gov/11025777/